Haematologica · 2008 · 82 citations · 21 references
MedicineHematologyPathologyCytogeneticsHematopathologyNeoplasiaCancer CytogeneticsHematologic MalignanciesHematopoietic NeoplasmsMolecular CytogeneticsMultiple MyelomaPlasma Cell NeoplasmsCytogenetic AbnormalitiesCytogenetics In Hematologic DiseaseDna In Situ HybridizationExtramedullary PlasmacytomaInterphase CytogeneticsMyeloma PathogenesisNeoplastic Cytogenetics
Primary extramedullary plasmacytoma is an indolent neoplasm that infrequently converts to multiple myeloma. Since cytogenetic data on extramedullary plasmacytoma are lacking, we studied 38 cases of this type of neoplasm by fluorescence in situ hybridization. Fourteen cases (37%) contained IGH breaks, including six with a t(4;14) translocation. No translocations t(11;14), t(14;16), t(8;14), nor breaks involving MALT1, BCL6 or FOXP1 were found. Loss of 13q (40%), as well as chromosomal gains (82%) were common. There was no correlation between chromosomal alterations and clinical features or local relapse. Cytogenetically, extramedullary plasmacytoma and multiple myeloma are closely related. However, the distribution of IGH translocation partners, with the notable absence of t(11;14), is different. Key words: extramedullary plasmacytoma, multiple myeloma, cytogenetics, IGH translocation, fluorescence in situ hybridization.
21
Genetics and Cytogenetics of Multiple Myeloma
Rafaël Fonseca, Bart Barlogie, Régis Bataille et al. · Cancer Research · 2004 · 686 citations
Clinical and biologic implications of recurrent genomic aberrations in myeloma
Rafaël Fonseca, Emily Blood, Montserrat Rué et al. · Blood · 2003 · 661 citations
Marta Chesi, Elena Nardini, Leslie A. Brents et al. · Nature Genetics · 1997 · 647 citations
Christoph Alexiou, Reinhardt J. Kau, Hermann Dietzfelbinger et al. · Cancer · 1999 · 567 citations · Full text